跳至主要内容
临床试验/NCT06331793
NCT06331793Unknown不适用

Use of a Wearable Device Which Generates an Electromagnetic Pulsed Field for Postoperative Analgesia of Mastectomies

European Institute of Oncology2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2023年5月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
160
试验地点
2
主要终点
Pain intensity

研究概览

简要总结

Study aim is to test AlgoCare, a device that uses the technology PEMF (Pulsed ElectroMagnetic Fields) for the treatment of postoperative pain in oncological breast surgery, in order to demonstrate that the use of Algocare in the postoperative period allows for a reduction in pain intensity in terms of Numerical Rating Scale (NRS) score and use of analgesic drugs.

详细描述

The treatment of postoperative pain is a priority issue for both the doctor and the patient. Obtaining adequate analgesia in the first postoperative days, in fact, is essential for the patient's comfort, but also to promote and accelerate functional recovery and prevent chronic pain, which in the case of breast surgery has a high incidence (20-60 %).

The use of pulsed electromagnetic fields (PEMF) for the treatment of pain and inflammation has been widely studied and validated.

Study aim is to test AlgoCare, a device that uses the technology PEMF (Pulsed ElectroMagnetic Fields), for the treatment of postoperative pain in oncological breast surgery. This is a field of application in which this technique analgesic has never been tested, but in which it could prove valid within a multimodal analgesia protocol, as the pain caused by this type of intervention is predominantly parietal and resulting from tissue trauma caused by the surgical wound. AlgoCare is a non-invasive and non-pharmacological device, developed specifically for treatment of post-operative inflammation and pain, CE certified and registered with the Ministry of Health. It emits a pulsed radio frequency electromagnetic field at 27.1 MHz, a frequency already studied and approved for medical use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Double blind

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Breast cancer patients undergoing unilateral mastectomy with reconstruction and without axillary dissection

排除标准

  • Patients with PaceMakers (PMs), Implantable Cardioverter Defibrillators (ICDs), neurostimulators or other active medical devices or metal implants near the application area
  • Pregnancy
  • Amyloidosis, sarcoidosis, scleroderma, infectious arthritis, Paget's disease or joint tumors

研究组 & 干预措施

Active AlgoCare

Experimental

An active AlgoCare device (that emits a pulsed radio frequency electromagnetic field at 27.1 MHz) will be placed over the surgical dressing using a plaster or bandage for six days.

干预措施: Active AlgoCare (Device)

Non-active AlgoCare

Placebo Comparator

A non-active AlgoCare device (that doesn't emit pulsed radio frequency electromagnetic field) will be placed over the surgical dressing using a plaster or bandage for six days.

干预措施: Non-active AlgoCare (Device)

结局指标

主要结局

Pain intensity

时间窗: 72 hours

Difference in mean NRS score between the two arms, at 24 hours and 72 hours after surgery (minimum value: 0, maximum value: 10 - higher scores mean a worse outcome)

次要结局

  • Patient reported pain characteristics(3 months)
  • Need for other drugs(3 months)
  • Number of participants with other symptoms(3 months)
  • Need for analgesic drugs(3 months)
  • Wound healing timing(3 months)

研究者

发起方
European Institute of Oncology
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验